IXICO Appoints New Chief Commercial Officer to Accelerate Neuroscience Imaging Business Growth
核心洞察
IXICO PLC has appointed Tanya Voloshen as its first chief commercial officer to strengthen commercial capabilities and accelerate business development activities.
Voloshen will be based in Boston, Massachusetts, to help broaden IXICO's footprint in the US market for neuroscience imaging services.
The new CCO brings extensive commercial leadership experience from neuroscience and medical imaging companies including Perceptive Inc (搜索), Clario (搜索), QMENTA (搜索) and ConcertAI (搜索).
IXICO PLC, an AIM-listed neuroscience imaging and biomarker analytics company, has appointed Tanya Voloshen as its chief commercial officer in a newly created role designed to accelerate business development activities and expand the company's presence in the United States market.
Strategic US Market Expansion
Voloshen will be based in Boston, Massachusetts, positioning IXICO to strengthen its commercial operations in the critical US market. The appointment represents a significant strategic move for the neuroscience imaging specialist as it seeks to capitalize on growing demand for clinical imaging services and biomarker analytics.
"I am very pleased to welcome Tanya to IXICO as CCO, a newly appointed position in the senior leadership team that reflects a firm and continued commitment to strengthen our commercial capabilities and accelerate growth," said chief executive Bram Goorden.
Extensive Industry Experience
The new chief commercial officer brings substantial experience in the neuroscience and medical imaging sectors. Voloshen joins IXICO from contract research organization Perceptive Inc (搜索), where she served as senior vice president of commercial operations. Her career includes senior commercial leadership positions at several prominent companies in the neuroscience and medical imaging space, including Clario (搜索), QMENTA (搜索), and ConcertAI (搜索).
Technology Platform Focus
According to CEO Goorden, Voloshen's appointment leverages her established customer relationships and deep understanding of how IXICO's technology platform can contribute to the clinical imaging market. "Based in Boston, Tanya brings strong commercial leadership experience, established customer relationships and an excellent understanding of the critical contribution that IXICO's technology platform can make in the clinical imaging market," Goorden noted.
The appointment signals IXICO's intention to more aggressively pursue commercial opportunities in neuroscience imaging and biomarker analytics, sectors that are increasingly important for pharmaceutical companies conducting clinical trials and developing neurological therapies.